Israel, California Institute Sign Biotech Deal With Emphasis on Stem Cell Research
JNS.org – Israeli Science, Technology and Space Minister Ofir Akunis on Tuesday signed the first agreement of its kind between his ministry and the California Institute for Regenerative Medicine (CIRM) in the field of biotechnology, with an emphasis on stem cell research.
The agreement was facilitated by the Israeli-American Council (IAC), which encourages cooperation between the United States and Israel, and whose stated mission is “to build an active and giving Israeli-American community throughout the United States in order to strengthen the State of Israel, our next generation, and to provide a bridge to the Jewish-American community.”
The biotechnology deal is the “sharpest response to all the foolish initiatives to make academics boycott Israel, including here in California,” Akunis said at the signing ceremony, adding that “anyone who boycotts Israel — the loss is all his.”
Akunis continued, “This agreement will deepen the partnership between Israel and California, bringing together our most talented scientists to push the boundaries of stem cell research and advance medical breakthroughs in the treatment of diseases ranging from cancer and diabetes, to Alzheimer’s and HIV-AIDS.”
IAC Chairman Adam Milstein said at the event that the organization is “excited by the opportunity to promote one of the most pressing issues facing humanity, and strengthen the bond between the people of Israel and the American people.”
Dr. Jonathan Thomas, chairman of the CIRM Board, praised Israel’s scientific achievements.
“Israel has become an important center for stem cell research. As part of our new CIRM 2.0 approach to funding stem cell research, we want to attract the best science and most promising projects from everywhere in the world to California,” Thomas said.